ஆண்டர்ஸ் மார்டின் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆண்டர்ஸ் மார்டின். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆண்டர்ஸ் மார்டின் Today - Breaking & Trending Today

Oncopeptides publishes report for Q2 2021

/PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat. ....

United States , Martyj Duvall , Anders Martin , Rolf Gulliksen , Klaas Bakker , Linda Holmstr , European Hematology Association , Global Head Of Corporate Communications , Nasdaq Stockholm , Clinical Oncology , Anders Martin L , Global Head , Corporate Communications , Investor Relations , Abuse Regulation , Securities Markets , Mid Cap , Oncopeptides Ab , ஒன்றுபட்டது மாநிலங்களில் , ஆண்டர்ஸ் மார்டின் , ஐரோப்பிய ஹீமாட்டாலஜி சங்கம் , உலகளாவிய தலை ஆஃப் பெருநிறுவன தகவல்தொடர்புகள் , நாஸ்டாக் ஸ்டாக்‌ஹோல்ம் , மருத்துவ புற்றுநோயியல் , ஆண்டர்ஸ் மார்டின் ல் , உலகளாவிய தலை ,

Annual General Meeting in Cantargia AB (publ)

STOCKHOLM, May 26, 2021 /PRNewswire/ Cantargia's Annual General Meeting on 26 May 2021 resolved in accordance with the following: That no dividend would be paid To discharge the board ....

Anders Martin , Magnus Nilsson , Flavia Borellini , Karin Leandersson , Thoas Fioretos , Damian Marron , Magnus Persson , Patricia Delaite , Annual General Meeting , Anders Martin L , Nasdaq Stockholm , ஆண்டர்ஸ் மார்டின் , மேக்னஸ் நில்சன் , டாமியன் மரோன் , மேக்னஸ் பெர்சன் , ஆண்டு ஜநரல் சந்தித்தல் , ஆண்டர்ஸ் மார்டின் ல் , நாஸ்டாக் ஸ்டாக்‌ஹோல்ம் ,

Oncopeptides publishes report for Q1 2021 and updated dates for the publication of the reports for Q2 and Q3 2021

Oncopeptides publishes report for Q1 2021 and updated dates for the publication of the reports for Q2 and Q3 2021
A strong start for PEPAXTO in the US
News provided by
Share this article
Share this article
STOCKHOLM, May 26, 2021 /PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, has today published the report for the first quarter 2021.
Oncopeptides now stands proudly among the few companies that have successfully navigated the long and difficult path from discovery to commercialization says CEO, Marty J Duvall.
Financial overview January-March
Operating loss amounted to SEK 347.3 M (loss: 296.9) ....

United States , Martyj Duvall , Anders Martin , Rolf Gulliksen , Klaas Bakker , Linda Holmstr , Global Head Of Corporate Communications , Nasdaq Stockholm , Multiple Myeloma Clinical Practice Guidelines , National Comprehensive Cancer Network , Anders Martin L , Global Head , Corporate Communications , Investor Relations , Mid Cap , ஒன்றுபட்டது மாநிலங்களில் , ஆண்டர்ஸ் மார்டின் , கிளாஸ் பேக்கர் , உலகளாவிய தலை ஆஃப் பெருநிறுவன தகவல்தொடர்புகள் , நாஸ்டாக் ஸ்டாக்‌ஹோல்ம் , பல மைலோமா மருத்துவ ப்ர்யாக்டீஸ் வழிகாட்டுதல்கள் , தேசிய விரிவான புற்றுநோய் வலைப்பின்னல் , ஆண்டர்ஸ் மார்டின் ல் , உலகளாவிய தலை , பெருநிறுவன தகவல்தொடர்புகள் , முதலீட்டாளர் உறவுகள் ,

Oncopeptides AB: Phase 3 OCEAN study demonstrates that melflufen is at least as efficacious as pomalidomide, the most used medicine in relapsed refractory multiple myeloma

/PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat. ....

United States , United Kingdom , Martyj Duvall , Anders Martin , Rolf Gulliksen , Klaas Bakker , Linda Holmstr , Jakob Lindberg , American Society Of Hematology , University Of Rotterdam , Drug Administration , Global Head Of Corporate Communications , Nasdaq Stockholm , Chief Executive Officer , Hazard Ratio , Overall Response Rate , Principal Investigator , Executive Vice President , Chief Medical Officer , New Drug Application , American Society , Global Head , Corporate Communications , Progression Free , Mid Cap , Oncopeptides Ab ,

Notice of annual general meeting in Cantargia AB (publ)

Notice of annual general meeting in Cantargia AB (publ)
STOCKHOLM, April 27, 2021 /PRNewswire/
The shareholders of Cantargia AB (publ) are invited to the annual general meeting on Wednesday, 26 May 2021. In light of the corona virus, the meeting is conducted through advance voting pursuant to temporary regulations. Therefore, it will not be possible to attend the meeting in person or by proxy.
Notification of participation, etc.
A shareholder who would like to participate in the meeting must (i) be entered in the register of shareholders maintained by Euroclear Sweden AB by Tuesday, 18 May 2021, and (ii) announce their participation no later than Tuesday, 25 May 2021, by having submitted an advance voting form in accordance with the instructions in the section Advance voting below such that the company has received the advance vote no later than this date. ....

United Kingdom , Uppsala Lan , Anders Martin , Magnus Nilsson , Flavia Borellini , Karin Leandersson , Mikael Wiberg Alecta Pensionsf , Resolys Bio , Thoas Fioretos , Karo Bio , Marianne Nilsson Swedbank , Damian Marron , Magnus Persson , Claus Asbj , Patricia Delaite , Uppsala University , Swedish Companies Registration Office Sw , Cytoseek Ltd , Jannis Kitsakis Fourth Swedish National Pension Fund , Employee Option Program , University Of Liverpool , Agalimmune Ltd , Head Of European Business Development , M Health Care , Imophoron Ltd , A Implementation Of Employee Option Program ,